[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367359-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-367359-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","artificial-intelligence-utilization-in-cancer-screening-program-across-asean-a-scoping-review","Artificial intelligence utilization in cancer screening program across ASEAN - a scoping review","","Cancer remains a significant health challenge across ASEAN, with screening approaches, target groups, and screening intervals differing among member states. Artificial intelligence (AI) offers potential support for cancer screening, yet its utilization in ASEAN remains insufficiently understood. This scoping review uses PRISMA-ScR to map cancer screening programs and AI usage, collecting data from government health ministries, official guidelines, and literature sources from January 2019 to May 2024.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/artificial-intelligence-utilization-in-cancer-screening-program-across-asean-a-scoping-review/367359/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/artificial-intelligence-utilization-in-cancer-screening-program-across-asean-a-scoping-review/367359.png","ImageObject",300,407,{"name":42,"@type":43},"Jake","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What screening differences exist across ASEAN member states?","Question",{"text":63,"@type":64},"The review reports that countries such as Myanmar, Laos, Cambodia, Vietnam, Brunei, Philippines, Indonesia, and Timor-Leste mainly use opportunistic screening, while Singapore, Malaysia, and Thailand focus on organized programs.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was AI integration assessed in this scoping review?",{"text":68,"@type":64},"AI usage in cancer screening was evaluated through a scoping review following PRISMA-ScR guidelines, with searches in PubMed, Scopus, and Google Scholar for studies using ASEAN-region data from January 2019 to May 2024.",{"name":70,"@type":61,"acceptedAnswer":71},"What cancer types and AI implementation stages were found?",{"text":72,"@type":64},"Fourteen studies were included across breast, cervical, colon, hepatic, lung, and oral cancers. AI integration was reported as prospective clinical evaluation (50%), silent trial (36%), and exploratory model development (14%).",{"name":74,"@type":61,"acceptedAnswer":75},"What recommendations does the study make for future cancer screening in ASEAN?",{"text":76,"@type":64},"The study calls for more organized approaches targeting appropriate age groups at regular intervals to meet WHO 2030 screening targets, highlighting that AI integration may optimize screening processes, reduce costs, and improve early detection.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},367359,1790497204,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,109,114,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":106,"show_sort_weight":107,"slug":108},"Technology",50,"technology",{"id":110,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},7,"Healthcare",40,"healthcare",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},8,30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":115,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":112,"preview_page_count":33,"preview_urls":149},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Tun etal. BMC Cancer (2025) 25:703  \n[https://doi.org/10.1186/s12885-025-14026-x](https://doi.org/10.1186/s12885-025-14026-x)  \nBMC Cancer  \n SYSTEMATIC REVIEW Open Access  \nArtificial intelligence utilization in cancer screening program across ASEAN: a scoping review  \nHein Minn Tun1,2*, Hanif Abdul Rahman1,2, Lin Naing1 and Owais Ahmed Malik2  \nAbstract  \nBackground Cancer remains a significant health challenge in the ASEAN region, highlighting the need for effective screening programs. However, approaches, target demographics, and intervals vary across ASEAN member states, necessitating a comprehensive understanding of these variations to assess program effectiveness. Additionally, while artificial intelligence (AI) holds promise as a tool for cancer screening, its utilization in the ASEAN region is unexplored.  \nPurpose This study aims to identify and evaluate different cancer screening programs across ASEAN, with a focus on assessing the integration and impact of AI in these programs.  \nMethods A scoping review was conducted using PRISMA-ScR guidelines to provide a comprehensive overview of cancer screening programs and AI usage across ASEAN. Data were collected from government health ministries, official guidelines, literature databases, and relevant documents. The use of AI in cancer screening reviews involved searches through PubMed, Scopus, and Google Scholar with the inclusion criteria of only included studies that utilized data from the ASEAN region from January 2019 to May 2024.  \nResults The findings reveal diverse cancer screening approaches in ASEAN. Countries like Myanmar, Laos, Cambodia, Vietnam, Brunei, Philippines, Indonesia and Timor-Leste primarily adopt opportunistic screening, while Singapore, Malaysia, and Thailand focus on organized programs. Cervical cancer screening is widespread, using both opportunistic and organized methods. Fourteen studies were included in the scoping review, covering breast (5 studies), cervical (2 studies), colon (4 studies), hepatic (1 study), lung (1 study), and oral (1 study) cancers. Studies revealed that different stages of AI integration for cancer screening: prospective clinical evaluation (50%), silent trial (36%) and exploratory model development (14%), with promising results in enhancing cancer screening accuracy and efficiency. Conclusion Cancer screening programs in the ASEAN region require more organized approaches targeting appropriate age groups at regular intervals to meet the WHO’s 2030 screening targets. Efforts to integrate AI in Singapore, Malaysia, Vietnam, Thailand, and Indonesia show promise in optimizing screening processes, reducing costs, and improving early detection. AI technology integration enhances cancer identification accuracy during screening, improving early detection and cancer management across the ASEAN region.  \nKeywords Cancer screening, Artificial intelligence, ASEAN  \n*Correspondence: Hein Minn Tun [23H8750@ubd.edu.bn](23H8750@ubd.edu.bn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the cop","cbCaihE69y4Yt3Yv","https://ap.wps.com/l/cbCaihE69y4Yt3Yv","pdf",1531890,16,"English","# Abstract\n## Background\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Background","[{\"question\":\"What screening differences exist across ASEAN member states?\",\"answer\":\"The review reports that countries such as Myanmar, Laos, Cambodia, Vietnam, Brunei, Philippines, Indonesia, and Timor-Leste mainly use opportunistic screening, while Singapore, Malaysia, and Thailand focus on organized programs.\"},{\"question\":\"How was AI integration assessed in this scoping review?\",\"answer\":\"AI usage in cancer screening was evaluated through a scoping review following PRISMA-ScR guidelines, with searches in PubMed, Scopus, and Google Scholar for studies using ASEAN-region data from January 2019 to May 2024.\"},{\"question\":\"What cancer types and AI implementation stages were found?\",\"answer\":\"Fourteen studies were included across breast, cervical, colon, hepatic, lung, and oral cancers. AI integration was reported as prospective clinical evaluation (50%), silent trial (36%), and exploratory model development (14%).\"},{\"question\":\"What recommendations does the study make for future cancer screening in ASEAN?\",\"answer\":\"The study calls for more organized approaches targeting appropriate age groups at regular intervals to meet WHO 2030 screening targets, highlighting that AI integration may optimize screening processes, reduce costs, and improve early detection.\"}]","Artificial intelligence utilization in cancer screening program across ASEAN - a scoping review | PDF",1790170455,[150,154,158,162],{"page_no":22,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/11f60045027aea5fa8c4ac237ccb4150.webp",983,1305,{"page_no":26,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1efd9f47f4df354db78d61b32feeebd8.webp",982,1304,{"page_no":30,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfa9f0b5330804baebc9ce936e713133.webp",981,1303,{"page_no":33,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d48720743cb9b781c6ed0fe1e8a1e04.webp",980,1301]